These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 33317573)

  • 1. Myeloid-derived suppressor cells therapy enhance immunoregulatory properties in acute graft versus host disease with combination of regulatory T cells.
    Park MJ; Baek JA; Kim SY; Jung KA; Choi JW; Park SH; Kwok SK; Cho ML
    J Transl Med; 2020 Dec; 18(1):483. PubMed ID: 33317573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
    Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
    Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
    Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
    Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
    Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex Vivo Generated Human Cord Blood Myeloid-Derived Suppressor Cells Attenuate Murine Chronic Graft-versus-Host Diseases.
    Lim JY; Ryu DB; Park MY; Lee SE; Park G; Kim TG; Min CK
    Biol Blood Marrow Transplant; 2018 Dec; 24(12):2381-2396. PubMed ID: 30006304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIF-1α inhibitor echinomycin reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.
    Yao Y; Wang L; Zhou J; Zhang X
    J Transl Med; 2017 Feb; 15(1):28. PubMed ID: 28183349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking activator protein 1 activity in donor cells reduces severity of acute graft-versus-host disease through reciprocal regulation of IL-17-producing T cells/regulatory T cells.
    Park MJ; Moon SJ; Lee SH; Kim EK; Yang EJ; Min JK; Park SH; Kim HY; Yang CW; Cho ML
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1112-20. PubMed ID: 24813170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTOR inhibitor rapamycin induce polymorphonuclear myeloid-derived suppressor cells mobilization and function in protecting against acute graft-versus-host disease after bone marrow transplantation.
    Lin Y; Wang B; Shan W; Tan Y; Feng J; Xu L; Wang L; Han B; Zhang M; Yu J; Yu X; Huang H
    Clin Immunol; 2018 Feb; 187():122-131. PubMed ID: 29132870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient treatment of murine acute GvHD by in vitro expanded donor regulatory T cells.
    Riegel C; Boeld TJ; Doser K; Huber E; Hoffmann P; Edinger M
    Leukemia; 2020 Mar; 34(3):895-908. PubMed ID: 31719679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating CD14(+) HLA-DR(-/low) myeloid-derived suppressor cells in leukemia patients with allogeneic hematopoietic stem cell transplantation: novel clinical potential strategies for the prevention and cellular therapy of graft-versus-host disease.
    Yin J; Wang C; Huang M; Mao X; Zhou J; Zhang Y
    Cancer Med; 2016 Jul; 5(7):1654-69. PubMed ID: 27109254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-IL-22 Antibody Attenuates Acute Graft-versus-Host Disease via Increasing Foxp3
    Wu J; Gu J; Zhou S; Lu H; Lu Y; Lu L; Wang X
    J Immunol Res; 2018; 2018():1605341. PubMed ID: 30159338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-17C Mitigates Murine Acute Graft-vs.-Host Disease by Promoting Intestinal Barrier Functions and Treg Differentiation.
    Gong H; Ma S; Liu S; Liu Y; Jin Z; Zhu Y; Song Y; Lei L; Hu B; Mei Y; Liu H; Liu Y; Wu Y; Dong C; Xu Y; Wu D; Liu H
    Front Immunol; 2018; 9():2724. PubMed ID: 30534126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LYG1 Deficiency Attenuates the Severity of Acute Graft-Versus-Host Disease
    Liu H; Yu Z; Tang B; Miao S; Qin C; Li Y; Liang Z; Shi Y; Zhang Y; Wang Q; Yan M; Song Z; Ren H; Dong Y
    Front Immunol; 2021; 12():647894. PubMed ID: 34262560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic Effects.
    Wang L; Ni M; Hückelhoven-Krauss A; Sellner L; Hoffmann JM; Neuber B; Luft T; Hegenbart U; Schönland S; Kleist C; Sill M; Chen BA; Wuchter P; Eckstein V; Krüger W; Hilgendorf I; Yerushalmi R; Nagler A; Müller-Tidow C; Ho AD; Dreger P; Schmitt M; Schmitt A
    Front Immunol; 2018; 9():2207. PubMed ID: 30349527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of therapeutic potential of monocytic myeloid-derived suppressor cells in cardiac allotransplantation.
    Fujimoto K; Uchida K; Yin E; Zhu J; Kojima Y; Uchiyama M; Yamamoto Y; Bashuda H; Matsumoto R; Tokushige K; Harada M; Inomata T; Kitaura J; Murakami A; Okumura K; Takeda K
    Transpl Immunol; 2021 Aug; 67():101405. PubMed ID: 33975012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of Graft-Versus-Host Disease Control Efficacy by Adoptive Transfer of Type 1 Regulatory T Cells in Bone Marrow Transplant Model.
    Jeon YW; Lim JY; Im KI; Kim N; Nam YS; Song YJ; Cho SG
    Stem Cells Dev; 2019 Jan; 28(2):129-140. PubMed ID: 30381994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Lkb1 impairs Treg function and stability to aggravate graft-versus-host disease after bone marrow transplantation.
    Su X; Wang Q; Guo W; Pei X; Niu Q; Liu M; Liu Y; Chen S; Feng S; He Y; Yang D; Zhang R; Ma Q; Zhai W; Pang A; Wei J; Huang Y; Luo Y; Han M; Feng X; Jiang E
    Cell Mol Immunol; 2020 May; 17(5):483-495. PubMed ID: 31664223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GRIM19 ameliorates acute graft-versus-host disease (GVHD) by modulating Th17 and Treg cell balance through down-regulation of STAT3 and NF-AT activation.
    Park MJ; Lee SH; Lee SH; Kim EK; Lee EJ; Moon YM; La Cho M
    J Transl Med; 2016 Jul; 14(1):206. PubMed ID: 27391226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-10 produced by myeloid-derived suppressor cells is critical for the induction of Tregs and attenuation of rheumatoid inflammation in mice.
    Park MJ; Lee SH; Kim EK; Lee EJ; Baek JA; Park SH; Kwok SK; Cho ML
    Sci Rep; 2018 Feb; 8(1):3753. PubMed ID: 29491381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid-derived Suppressor Cells Recruit CD4(+)/Foxp3(+) Regulatory T Cells in a Murine Cardiac Allograft.
    Nakamura T; Nakao T; Ashihara E; Yoshimura N
    Transplant Proc; 2016 May; 48(4):1275-8. PubMed ID: 27320602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.